{"id":"https://openalex.org/W1985102822","doi":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","title":"Engineered therapeutic antibodies with improved effector functions","display_name":"Engineered therapeutic antibodies with improved effector functions","publication_year":2009,"publication_date":"2009-05-18","ids":{"openalex":"https://openalex.org/W1985102822","doi":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","mag":"1985102822","pmid":"https://pubmed.ncbi.nlm.nih.gov/19538497","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11159150"},"language":"en","primary_location":{"id":"doi:10.1111/j.1349-7006.2009.01222.x","doi":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11159150","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046832425","display_name":"Tsuguo Kubota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsuguo Kubota","raw_affiliation_strings":["Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044584457","display_name":"Rinpei Niwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Rinpei Niwa","raw_affiliation_strings":["Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085088469","display_name":"Mitsuo Satoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuo Satoh","raw_affiliation_strings":["Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Machida-shi, Tokyo","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110048396","display_name":"Shiro Akinaga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiro Akinaga","raw_affiliation_strings":["Departments of Clinical Development"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Development","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109957616","display_name":"Kenya Shitara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenya Shitara","raw_affiliation_strings":["Strategic Product Planning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Strategic Product Planning","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031607600","display_name":"Nobuo Hanai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuo Hanai","raw_affiliation_strings":["Development Division, Kyowa Hakko Kirin Co., Ltd, Chiyoda-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Development Division, Kyowa Hakko Kirin Co., Ltd, Chiyoda-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044584457"],"corresponding_institution_ids":["https://openalex.org/I205823427"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":null,"fwci":1.241,"has_fulltext":false,"cited_by_count":156,"citation_normalized_percentile":{"value":0.77859779,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"100","issue":"9","first_page":"1566","last_page":"1572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.9309999942779541},{"id":"https://openalex.org/keywords/fc-engineering","display_name":"Fc engineering","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antibody-effector-functions","display_name":"antibody effector functions","score":0.7919999957084656},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9769999980926514},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fc-receptors","display_name":"Fc receptors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.7639999985694885},{"id":"https://openalex.org/keywords/c1q","display_name":"C1q","score":0.949999988079071},{"id":"https://openalex.org/keywords/fcrn","display_name":"neonatal Fc receptor","score":0.996999979019165},{"id":"https://openalex.org/keywords/antibody-half-life","display_name":"antibody half-life","score":0.9279999732971191},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.875},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.964054524898529},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7257911562919617},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5874044299125671},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5455493330955505},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.5405354499816895},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5343097448348999},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.46220752596855164},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3990710973739624},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.22318238019943237},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22293004393577576},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14564141631126404},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015202","descriptor_name":"Protein Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1349-7006.2009.01222.x","doi":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2009.01222.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11159150","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11159150","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"},{"id":"pmid:19538497","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19538497","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11159150","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11159150","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W33733012","https://openalex.org/W60759546","https://openalex.org/W147375797","https://openalex.org/W1220980554","https://openalex.org/W1484092314","https://openalex.org/W1512026049","https://openalex.org/W1518819083","https://openalex.org/W1529809181","https://openalex.org/W1563403908","https://openalex.org/W1565489899","https://openalex.org/W1571909667","https://openalex.org/W1589026573","https://openalex.org/W1863867804","https://openalex.org/W1897592311","https://openalex.org/W1906100218","https://openalex.org/W1915689252","https://openalex.org/W1952749171","https://openalex.org/W1960953338","https://openalex.org/W1965962344","https://openalex.org/W1971724092","https://openalex.org/W1973073597","https://openalex.org/W1978410756","https://openalex.org/W1979336667","https://openalex.org/W1983494459","https://openalex.org/W1985701112","https://openalex.org/W1988665558","https://openalex.org/W1996045402","https://openalex.org/W1998297552","https://openalex.org/W2009671611","https://openalex.org/W2009900556","https://openalex.org/W2016973656","https://openalex.org/W2017344199","https://openalex.org/W2020647630","https://openalex.org/W2023765040","https://openalex.org/W2029458645","https://openalex.org/W2032454178","https://openalex.org/W2037007095","https://openalex.org/W2039155298","https://openalex.org/W2039609199","https://openalex.org/W2044360617","https://openalex.org/W2050376954","https://openalex.org/W2051999609","https://openalex.org/W2059347528","https://openalex.org/W2061345986","https://openalex.org/W2063840206","https://openalex.org/W2064046777","https://openalex.org/W2064283997","https://openalex.org/W2064839836","https://openalex.org/W2065219066","https://openalex.org/W2065419141","https://openalex.org/W2068635250","https://openalex.org/W2075097399","https://openalex.org/W2077291494","https://openalex.org/W2081867678","https://openalex.org/W2082983474","https://openalex.org/W2083706383","https://openalex.org/W2084136419","https://openalex.org/W2085992950","https://openalex.org/W2091291743","https://openalex.org/W2093572741","https://openalex.org/W2105141160","https://openalex.org/W2107426197","https://openalex.org/W2108958978","https://openalex.org/W2111262648","https://openalex.org/W2115571948","https://openalex.org/W2122725450","https://openalex.org/W2126529136","https://openalex.org/W2130611069","https://openalex.org/W2133105825","https://openalex.org/W2133626640","https://openalex.org/W2135668465","https://openalex.org/W2138847695","https://openalex.org/W2143562636","https://openalex.org/W2156750419","https://openalex.org/W2157769714","https://openalex.org/W2160798258","https://openalex.org/W2168648203","https://openalex.org/W2168750246","https://openalex.org/W2264636885","https://openalex.org/W2264655007","https://openalex.org/W2318605753","https://openalex.org/W2548244535","https://openalex.org/W2552970357","https://openalex.org/W2979202014","https://openalex.org/W4206701382"],"related_works":["https://openalex.org/W2287054967","https://openalex.org/W2035343873","https://openalex.org/W2892240690","https://openalex.org/W2165271142","https://openalex.org/W7161036528","https://openalex.org/W2752201538","https://openalex.org/W2986511818","https://openalex.org/W2143562636","https://openalex.org/W101392706","https://openalex.org/W2325759540"],"abstract_inverted_index":{"In":[0],"the":[1,21,65,85,94,101,105,141],"past":[2],"decade,":[3],"more":[4],"than":[5],"20":[6],"therapeutic":[7,54,106,128],"antibodies":[8],"have":[9,46],"been":[10,47],"approved":[11],"for":[12,73,76,82,140,152],"clinical":[13,22,51,158],"use":[14],"and":[15,23,42,78,100,130],"many":[16],"others":[17],"are":[18,58,149],"now":[19,150],"at":[20],"preclinical":[24],"stage":[25],"of":[26,53,64,84,97,104,143,147,154],"development.":[27],"Fragment":[28],"crystallizable":[29],"(Fc)-dependent":[30],"antibody":[31,90,118],"functions,":[32,145],"such":[33],"as":[34,49],"antibody-dependent":[35],"cell-mediated":[36],"cytotoxicity":[37,40],"(ADCC),":[38],"complement-dependent":[39],"(CDC),":[41],"a":[43],"long":[44],"half-life,":[45],"suggested":[48],"important":[50],"mechanisms":[52],"antibodies.":[55],"These":[56],"functions":[57],"primarily":[59],"triggered":[60],"through":[61],"direct":[62],"interaction":[63],"Fc":[66,80,137],"domain":[67],"with":[68],"its":[69],"corresponding":[70],"receptors:":[71],"FcgammaRIIIa":[72],"ADCC,":[74],"C1q":[75],"CDC,":[77],"neonatal":[79],"receptor":[81],"prolongation":[83],"clearance":[86],"rate.":[87],"However,":[88],"current":[89],"therapy":[91],"still":[92],"faces":[93],"critical":[95],"issues":[96,113],"insufficient":[98],"efficacy":[99],"high":[102],"cost":[103],"agents.":[107],"A":[108],"possible":[109],"solution":[110],"to":[111,116,120,126],"these":[112],"could":[114],"be":[115],"engineer":[117],"molecules":[119],"enhance":[121],"their":[122,155],"antitumor":[123],"activity,":[124],"leading":[125],"improved":[127],"outcomes":[129],"reduced":[131],"doses.":[132],"Here,":[133],"we":[134],"review":[135],"advanced":[136],"engineering":[138],"approaches":[139],"enhancement":[142],"effector":[144],"some":[146],"which":[148],"ready":[151],"evaluation":[153],"effectiveness":[156],"in":[157],"trials.":[159]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}